0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

From the JAMA Network |  May 15, 2013
Do TNF Inhibitors Reduce the Risk of Myocardial Infarction in Psoriasis Patients?
April W. Armstrong, MD, MPH
JAMA. 2013;309(19):2043-2044. doi:10.1001/jama.2013.4695.
Editorial |  May 01, 2013
HPV Vaccination:  Too Soon for 2 Doses?
Jessica A. Kahn, MD, MPH; David I. Bernstein, MD, MA
JAMA. 2013;309(17):1832-1834. doi:10.1001/jama.2013.4147.
Original Contribution |  May 01, 2013
Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women:  A Randomized Clinical Trial
Simon R. M. Dobson, MD; Shelly McNeil, MD; Marc Dionne, MD; et al.
JAMA. 2013;309(17):1793-1802. doi:10.1001/jama.2013.1625.
INCLUDES: , Supplemental Content
Health Agencies Update |  April 24, 2013
Transplant-Related Rabies
Bridget M. Kuehn, MSJ
JAMA. 2013;309(16):1674. doi:10.1001/jama.2013.4241.
JAMA Clinical Challenge |  April 17, 2013 FREE
Edematous Erythema, Subcutaneous Plaques, and Severe Pain in the Lower Extremities in an Immunocompromised Patient
Ying-Guo Ding, MD, PhD; Hong Fang, MD, MPhil
JAMA. 2013;309(15):1632-1633. doi:10.1001/jama.2013.3740.
From the Centers for Disease Control and Prevention |  April 03, 2013 FREE
Thrombotic Thrombocytopenic Purpura (TTP)–Like Illness Associated With Intravenous Opana ER Abuse—Tennessee, 2012
JAMA. 2013;309(13):1338-1340. doi:10.1001/jama.2013.357.
JAMA Patient Page |  March 27, 2013 FREE
Treatment of Varicose Veins
Allen Hamdan, MD; Edward H. Livingston, MD; Cassio Lynm, MA
JAMA. 2013;309(12):1306. doi:10.1001/jama.2013.1704.
INCLUDES: , Supplemental Content
Global Health |  March 20, 2013
Control of River Blindness
M. J. Friedrich
JAMA. 2013;309(11):1101. doi:10.1001/jama.2013.2398.
Lab Reports |  March 06, 2013
Blue Light for Skin Infections
Tracy Hampton, PhD
JAMA. 2013;309(9):865. doi:10.1001/jama.2013.1846.
Editorial |  February 13, 2013
Antibiotics for Skin Infections:  New Study Design and a Step Toward Shorter Course Therapy
Shira Doron, MD; Helen W. Boucher, MD
JAMA. 2013;309(6):609-611. doi:10.1001/jama.2013.604.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  May 16, 2013
Association of Ocular and Oculodermal Melanocytosis With the Rate of Uveal Melanoma Metastasis:  Analysis of 7872 Consecutive Eyes
Carol L. Shields, MD; Swathi Kaliki, MD; Michael Livesey, BS; et al.
JAMA Dermatology
Observation  |  May 8, 2013
Anti–Laminin-332 Mucous Membrane Pemphigoid Developing After a Diphtheria Tetanus Vaccination
Tanya Sezin, MSc; Ella Egozi, MD; Wissam Hillou, MD; et al.
JAMA Dermatology
Study  |  May 8, 2013
Impact of Sunscreens on Preventing UVR-Induced Effects in Nevi:  In Vivo Study Comparing Protection Using a Physical Barrier vs Sunscreen
Cristina Carrera, MD; Joan A. Puig-Butillè, BMSc; Paula Aguilera, MD; et al.
JAMA Dermatology
Research Letters  |  May 8, 2013
Effects of a Chemical Sunscreen on UV-Induced Changes of Different Histological Features in Melanocytic Nevi
Cesare Massone, MD; Peter Wolf, MD; Stephan Gringschl, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems